BlackRock’s Cogentix Medical, Inc. CGNT Stock Holding History

BlackRock’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-86,959	Closed	-$335K	–	5182
2018 Q1	$335K	Sell	86,959 -7,584	-8%	-$23.7K	﹤0.01%	4109
2017 Q4	$298K	Sell	94,543 -2,184	-2%	-$6.29K	﹤0.01%	4131
2017 Q3	$247K	Sell	96,727 -1,828	-2%	-$4K	﹤0.01%	4189
2017 Q2	$171K	Buy	98,555 +60,090	+156%	+$103K	﹤0.01%	4295
2017 Q1	$69K	Buy	+38,465	New	+$76K	﹤0.01%	4405

BlackRock's CGNT Position: Q2 2018 in Review

BlackRock sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 86,959 shares — an estimated $335K sold.

BlackRock first reported a position in CGNT in Q1 2017 and held it in 5 quarters. The position peaked at $335K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

BlackRock reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
BlackRock sold 86,959 Cogentix Medical, Inc. shares in Q2 2018, an estimated $335K.
BlackRock first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 5 quarters.
BlackRock's Cogentix Medical, Inc. position peaked at $335K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on BlackRock's 13F filing for Q2 2018, filed 9 Aug 2018.